AZN.L - AstraZeneca PLC
LSE - LSE Delayed price. Currency in GBp
Currency in GBp
Valuation measures
| Market cap (intra-day) 5 | 94.23B |
| Enterprise value 3 | 112.26B |
| Trailing P/E | 45.06 |
| Forward P/E 1 | N/A |
| PEG ratio (5-yr expected) 1 | N/A |
| Price/sales (ttm) | 3.90 |
| Price/book (mrq) | 774.78 |
| Enterprise value/revenue 3 | 4.65 |
| Enterprise value/EBITDA 6 | 26.54 |
Trading information
Stock price history
| Beta (3Y monthly) | 0.20 |
| 52-week change 3 | 20.23% |
| S&P500 52-week change 3 | 19.27% |
| 52-week high 3 | 8,227.88 |
| 52-week low 3 | 109.51 |
| 50-day moving average 3 | 7,327.56 |
| 200-day moving average 3 | 6,920.33 |
Share statistics
| Avg vol (3-month) 3 | 2.2M |
| Avg vol (10-day) 3 | 2.87M |
| Shares outstanding 5 | 1.31B |
| Float | 1.31B |
| % held by insiders 1 | N/A |
| % held by institutions 1 | N/A |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 2.19 |
| Forward annual dividend yield 4 | 3.01% |
| Trailing annual dividend rate 3 | 2.80 |
| Trailing annual dividend yield 3 | 0.04% |
| 5-year average dividend yield 4 | 4.02 |
| Payout ratio 4 | 176.38% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 8 Aug 2019 |
| Last split factor (new per old) 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2018 |
| Most-recent quarter (mrq) | 30 Sep 2019 |
Profitability
| Profit margin | 8.52% |
| Operating margin (ttm) | 6.09% |
Management effectiveness
| Return on assets (ttm) | 1.53% |
| Return on equity (ttm) | 14.40% |
Income statement
| Revenue (ttm) | 24.14B |
| Revenue per share (ttm) | 18.72 |
| Quarterly revenue growth (yoy) | 20.00% |
| Gross profit (ttm) | 17.59B |
| EBITDA | 4.23B |
| Net income avi to common (ttm) | 2.06B |
| Diluted EPS (ttm) | 159.40 |
| Quarterly earnings growth (yoy) | -30.60% |
Balance sheet
| Total cash (mrq) | 4.78B |
| Total cash per share (mrq) | 3.64 |
| Total debt (mrq) | 20.31B |
| Total debt/equity (mrq) | 148.59 |
| Current ratio (mrq) | 0.92 |
| Book value per share (mrq) | 9.27 |
Cash flow statement
| Operating cash flow (ttm) | 3.82B |
| Levered free cash flow (ttm) | 5.83B |